Human Papillomavirus Genotypes in Invasive Cervical Carcinoma in HIV-Seropositive and HIV-Seronegative Women in Zimbabwe.   Presenting author: Dr Alltalents.

Slides:



Advertisements
Similar presentations
Group 3 – Michael, Elani, Golshan, Sarah, Joseph, Nana
Advertisements

HPV.  Many risk factors for development of cervical cancer. no routinely used positive predictive biological markers, which identify women at risk of.
PAPILLOMA VIRUSES. Papilloma Viruses Characteristics –dsDNA viruses (circular) –Genone 8 kbp –Genome associated with cellular histones –Naked capsid Widespread.
Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination Peter L. Stern Journal of Clinical Virology, 2005.
Update on HPV analysis in the Aberdeen Area Delf Schmidt-Grimminger Assistant Professor The University of South Dakota.
Cervical Cancer and HPV Z Mike Chirenje MD FRCOG University of Zimbabwe, Department of Obstetrics and Gynecology, Harare, Zimbabwe.
M. Munjoma. Outline Burden of HPV Disease HPV in Zimbabwe HPV Lab Development HPV Protocols.
Anticipated impact on HPV infection from HPV vaccination programs – cause for optimism Dr Paddy Horner.
Human Papilloma virus testing Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is Human Papillomavirus? Human papilloma.
H UMAN PAPILLOMAVIRUS AND BREAST CANCER Giles Davies An update on research progress.
Research on HBV in SCDC Xi Zhang, Ye Lu Shanghai Municipal Center for Disease Control and Prevention May, 2008.
P APOVAVIRUS FAMILY (P APOVAVIRIDAE ) : NOW 2 F AMILIES Papillomaviruses and Polyomaviruses.
A non-enveloped DNA virus which infects the skin/ mucous membranes of humans.
NIMR 6 th Annual Scientific Conference 10TH-12TH Nov. NIMR Auditorium, 6 Edmond Crescent, Yaba, Lagos. NIMR 6 th Annual Scientific Conference 10TH-12TH.
Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.
Chapter 29 Human Papilloma Virus Infection and Immunity.
N R Manyere UZ, College of Health Sciences Department of Obstetrics and Gynaecology.
Poster template by ResearchPosters.co.za INTRODUCTION ABAB RESULTS REFERENCES In Zimbabwe there is a significant rise in mortality and morbidity rate attributable.
TriCurin TM - a novel therapeutic for human papillomavirus infection
High-risk vaccine-specific HPV infection in HIV-infected and HIV-uninfected, vaccine-naïve Asian female adolescents (Abstract no. MOAB0206) Sricharoenchai.
SEXUALLY TRANSMITTED INFECTIONS
HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK
Demographics of Parents
Seroprevalence, prevalence, type and factors associated with HPV infection at multiple sites in young HIV-positive MSM On behalf of the HPV MAPS Research.
Cancers Linked to HPV Presenter: Chuck Lynch
INTRODUCTION: CERVICAL CANCER SCREENING
Prevalence of oncogenic Human Papillomavirus genotypes in women with vulvar and cervical squamous cell carcinoma in Botswana Patricia Rantshabeng1,2 ,
Clairette RAHARISOLO VOLOLONANTENAINA1 ,
2nd UNESCO-Merck Africa Research Summit,
Abstract 791 Impact of Birth PCR on Retention in Care of HIV Exposed Infants in Primary Care Aurelie Nelson1, Laura Trivino Duran1, Tali Cassidy1, Gilles.
PREVALENCE OF HEPATITIS B VIRUS INFECTION AMONG FEDERAL
Bibliometric Analysis of Human Papillomavirus Research
Comparative genotypic and phenotypic characterization of
Facilitator: Pawin Puapornpong
Viral infections and cancer
Risk factors for cervical intraepithelial neoplasia recurrence after loop electrosurgical excision procedure in HIV-1-infected and non-infected women.
Dr. Hasan Hüseyin Gümüşcü1, Dr. Kevser Onbaşı1, Dr. Nilgün Kaşifoğlu2
A. Latsuzbaia¹, J. Tapp¹, C. Ragimbeau¹, M. Fischer, S. Weyers², M
VIRUSES CHAPTER 10.
HPV VACCINES Dr. Kirtan Krishna.
27-29 September 2016 in Sanandaj, Kurdistan, Iran.
Secondhand smoke exposure and cervical cancer:
Dr Sam Hibbitts HPV Research Team Obstetrics & Gynaecology
Nasreen Abdullah, MD, MPH
Virology Introduction Viral Structure Bacteriophage Replication
Table 3. Demographic characteristics and liver function profiles of study participants.M PROTECTIVE ROLE OF MICRONUTRIENTS IN CURBING NON-COMMUNICABLE.
Introduction Viral Structure
Introduction to HPV Infection & Cervical Cancer Disease GardasilTM
Introduction to HPV Infection & Cervical Cancer Disease CervarixTM
Introduction to HPV Infection & Cervical Cancer Disease GardasilTM
Introduction to HPV Infection & Cervical Cancer Disease CervarixTM
Introduction to HPV Infection & Cervical Cancer Disease CervarixTM
The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional.
Viruses and Cancer.
The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional.
Papillomaviruses Papillomaviridae
Prevalence of vaccine type infections in vaccinated and non-vaccinated young women: HPV- IMPACT, a self-sampling study.   Jeannot E1,2, Viviano M3, de.
Virus Classification: The World of Viruses
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Viruses What are the characteristics of living organisms?
Phylogenetic tree showing generic and species positions based on Bayesian analysis of the nuclear ribosomal DNA 28S region (1,200 bp) of Schistosomatidae.
Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis  Chunqing Lin,
Seroreactivity of 38 Human Papillomavirus Types in Epidermodysplasia Verruciformis Patients, Relatives, and Controls  Kristina M. Michael, Tim Waterboer,
Research Techniques Made Simple: Interpreting Measures of Association in Clinical Research Michelle Roberts PhD,1,2 Sepideh Ashrafzadeh,1,2 Maryam Asgari.
The 7th EAHSC Detection of human papillomavirus DNA in tumors from Rwandese breast cancer patients Dr. Habyarimana T1,2,3, Attaleb M1, Mazarati JB3, Bakri.
Oncogenic Human Papillomavirus: Application of CRISPR/Cas9 Therapeutic Strategies for Cervical Cancer Cell Physiol Biochem 2017;44:2455– DOI: /
Hector H. García et al. Clin. Microbiol. Rev. 2002; doi: /CMR
Epidemiology of cervical cancer in India: Where do we stand today
Roberta B. Carey et al. Clin. Microbiol. Rev. 2018; doi: /CMR
Racheal S. Dube Mandishora, PhD
Presentation transcript:

Human Papillomavirus Genotypes in Invasive Cervical Carcinoma in HIV-Seropositive and HIV-Seronegative Women in Zimbabwe.   Presenting author: Dr Alltalents Tutsirayi Murahwa Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, 7925, South Africa.   Mudini W, Palefsky JM, Hale MJ, Chirenje MZ, Makunike-Mutasa R, Mutisi F, Mario A.  

HPV genera and species According to the most recent ICTV classification, the Papillomaviridae family includes two subfamilies Firstpapilomavirinae with more than 52 genera and Secondpapillomavirinae with one genus and one species”(Van Doorslaer et al., 2018) and a total of 133 species. Over 200 human papillomavirus (HPV) genotypes have been described with most falling into the Alpha, Beta and Gamma genera. HPVs associated with malignant anogenital cancers are found in the Alpha-PV genus. Very little has been published on Beta and Gamma-PVs in genital infections and almost nothing is known about these viruses in Africa. There is no published information on genital Beta- and Gamma-PVs in South Africans. Bayesian phylogenetic tree based on the L1 part of the complete 198 established HPV types, Bzhalava et al 2015

Background HPV Biology Papillomaviridae family Non-enveloped virus Double stranded circular DNA virus. Genome is approximately 8kb Typically it has 8 ORFs the early genes are for replication and transcription and the late are structural proteins. Establish productive infections in epithelial cells of the skin (cutaneous types) or mucous membranes (mucosotropic) doi: 10.1128/CMR.05028-11 Clin. Microbiol. Rev. April 2012 vol. 25no. 2 215-222

BACKGROUND: Invasive cervical carcinoma (ICC) accounts for 23% of all cancer- related deaths in Zimbabwean women. Trials for a national program of genotype-specific human papillomavirus (HPV) vaccines are underway to prevent cervical carcinoma, but the distribution of HPV types among women with ICC according to HIV status is unknown.

METHODS: To determine prevalence and distribution of high-risk HPV genotypes by HIV status in women with ICC. We performed a cross-sectional study on women referred for ICC testing at 4 urban referral hospitals in Zimbabwe from June 2014 to December 2015. Cervical biopsies were obtained for histology and HPV genotyping. HIV serology testing was performed. HPV testing was performed using MY09/MY11 polymerase chain reaction followed by typing using dot- blot hybridization.

RESULTS: Of 107 participants with histologically proven ICC, HIV prevalence was 49.5% (53/107). HIV-positive women tended to be younger (median age 44 years) than HIV- negative women (median age 59 years). HPV prevalence was 94% (101/107), ranging from 1 to 5 genotypes per participant. HPV 16 (81.5%), 18 (24%), 33 (13%), 35 (11%), 56 (9%), and 45 (7.4%) were the most prevalent genotypes among HIV- negative participants; HPV 16 (67.9%), 18 (43.4%), 56 (18.9%), 45 (15.1%), 33 (11.3%), and 58 (9.4%) were the most prevalent among HIV-positive participants. Eighty- three percent of women were infected with either HPV-16 or HPV-18.

CONCLUSIONS: Effective vaccination programs against HPV 16 and HPV 18 could prevent up to 83% of cases of cervical cancer in Zimbabwe. HIV may influence distribution of some HPV genotypes given the significant increase in prevalence of HPV 18 among HIV-positive participants.

Alltalents Tutsirayi Murahwa CHARACTERISATION AND EVOLUTIONARY DYNAMICS OF TEN NOVEL GAMMAPAPILLOMAVIRUS TYPES FROM SOUTH AFRICAN PENILE SWABS Alltalents Tutsirayi Murahwa PhD Medical Virology (UCT) , MPhil (MED) Immunology (UZ), Hons BMLS (UZ)

Laboratory workflow

Global scenario of PV evolution

Conclusion Discovery of more HPV viruses will enable a better understanding of both prophylactic and therapeutic strategies. Embracing next generation sequencing technologies is key to this goal.